AIM ImmunoTech Inc. AIM
0.16 USD 0.00 (+1.29%)
At closeNov 10, 2026, 5:06 AM EST
0.16 +0.01 +4.39%
Pre-market · Nov 10, 5:06 AM ET
0.1513 Day range 0.164
0.15 52-week range 1.82
- YTD
- -85.73%
- 1 year
- -90.37%
News
marketbeat.com What Aimia (AIM) Said on Its Q3 Earnings Call Aimia TSE: AIM reported higher third-quarter revenue as its Cortland business benefited from price increases and improving demand in several markets, while a write-down on its Clear Media investment…
globenewswire.com AIM ImmunoTech Highlights Ampligen® Opportunity to Potentially Extend Benefits of RAS-Targeted Therapies in Pancreatic Cancer New investor presentation outlines scientific rationale for combining Ampligen's immune-stimulating activity with daraxonrasib's targeted RAS inhibition to potentially prolong clinical benefit